Team shoos away superbugs with puffs of powder

Nanosized antibiotics could be the answer to superbugs.--Courtesy University of Sydney

Inhaled antibiotics could be a breath of fresh air for the treatment of respiratory infections, particularly ones caused by resistant bacteria, according to a researcher at the University of Sydney in Australia. Respiratory infections are increasingly being blamed on resistant bacteria (so-called superbugs), and the aggressive antibacterial agents needed to eliminate them have some unpleasant side effects, including severe diarrhea, nausea and vomiting, and even irreversible organ damage. A team at the university is developing powder inhalers delivering antibiotic nanoparticles, and believes that these might be a faster, safer and cheaper way of treating respiratory infections. Press release

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…